Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-25-000082
Filing Date
2025-08-08
Accepted
2025-08-08 07:01:33
Documents
97
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20250630.htm   iXBRL 10-Q 2017708
2 EX-31.1 anip-20250630x10qxexx311.htm EX-31.1 10152
3 EX-31.2 anip-20250630x10qxexx312.htm EX-31.2 9691
4 EX-32.1 anip-20250630x10qxexx321.htm EX-32.1 6919
  Complete submission text file 0001023024-25-000082.txt   11866644

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20250630.xsd EX-101.SCH 85723
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20250630_cal.xml EX-101.CAL 102324
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20250630_def.xml EX-101.DEF 507828
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20250630_lab.xml EX-101.LAB 965985
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20250630_pre.xml EX-101.PRE 727402
100 EXTRACTED XBRL INSTANCE DOCUMENT anip-20250630_htm.xml XML 1846009
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 251196161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)